Emcure Pharmaceuticals has inaugurated its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.
The new ERC facility is designed to accelerate pharmaceutical innovation with state-of-the-art laboratories and advanced equipment for each of the dosage forms. From early-stage pre-formulation studies to scaling-up, the ERC seamlessly integrates all aspects of pharmaceutical development while adhering to global regulatory standards.
With a focus on sustainable solutions and green chemistry practices, ERC reflects the company’s dedication to environmentally conscious innovations. It also serves as a catalyst for job creation and collaborations with academic institutions, industry experts and regulatory bodies, promoting an ecosystem of shared knowledge and growth.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1731.20 |
Dr. Reddys Lab | 1162.35 |
Cipla | 1483.00 |
Lupin | 2019.20 |
Zydus Lifesciences | 891.05 |
View more.. |